Intravitreal Injectable Market
1 Study Coverage
1.1 Intravitreal Injectable Product Introduction
1.2 Market by Drug
1.2.1 Global Intravitreal Injectable Market Size Growth Rate by Drug, 2017 VS 2021 VS 2028
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Market by Disease
1.3.1 Global Intravitreal Injectable Market Size Growth Rate by Disease, 2017 VS 2021 VS 2028
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravitreal Injectable Sales Estimates and Forecasts 2017-2028
2.2 Global Intravitreal Injectable Revenue Estimates and Forecasts 2017-2028
2.3 Global Intravitreal Injectable Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intravitreal Injectable Sales by Region
2.4.1 Global Intravitreal Injectable Sales by Region (2017-2022)
2.4.2 Global Sales Intravitreal Injectable by Region (2023-2028)
2.5 Global Intravitreal Injectable Revenue by Region
2.5.1 Global Intravitreal Injectable Revenue by Region (2017-2022)
2.5.2 Global Intravitreal Injectable Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intravitreal Injectable Sales by Manufacturers
3.1.1 Global Top Intravitreal Injectable Manufacturers by Sales (2017-2022)
3.1.2 Global Intravitreal Injectable Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravitreal Injectable in 2021
3.2 Global Intravitreal Injectable Revenue by Manufacturers
3.2.1 Global Intravitreal Injectable Revenue by Manufacturers (2017-2022)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2021
3.3 Global Intravitreal Injectable Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intravitreal Injectable Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Drug
4.1 Global Intravitreal Injectable Sales by Drug
4.1.1 Global Intravitreal Injectable Historical Sales by Drug (2017-2022)
4.1.2 Global Intravitreal Injectable Forecasted Sales by Drug (2023-2028)
4.1.3 Global Intravitreal Injectable Sales Market Share by Drug (2017-2028)
4.2 Global Intravitreal Injectable Revenue by Drug
4.2.1 Global Intravitreal Injectable Historical Revenue by Drug (2017-2022)
4.2.2 Global Intravitreal Injectable Forecasted Revenue by Drug (2023-2028)
4.2.3 Global Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
4.3 Global Intravitreal Injectable Price by Drug
4.3.1 Global Intravitreal Injectable Price by Drug (2017-2022)
4.3.2 Global Intravitreal Injectable Price Forecast by Drug (2023-2028)
5 Market Size by Disease
5.1 Global Intravitreal Injectable Sales by Disease
5.1.1 Global Intravitreal Injectable Historical Sales by Disease (2017-2022)
5.1.2 Global Intravitreal Injectable Forecasted Sales by Disease (2023-2028)
5.1.3 Global Intravitreal Injectable Sales Market Share by Disease (2017-2028)
5.2 Global Intravitreal Injectable Revenue by Disease
5.2.1 Global Intravitreal Injectable Historical Revenue by Disease (2017-2022)
5.2.2 Global Intravitreal Injectable Forecasted Revenue by Disease (2023-2028)
5.2.3 Global Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
5.3 Global Intravitreal Injectable Price by Disease
5.3.1 Global Intravitreal Injectable Price by Disease (2017-2022)
5.3.2 Global Intravitreal Injectable Price Forecast by Disease (2023-2028)
6 North America
6.1 North America Intravitreal Injectable Market Size by Drug
6.1.1 North America Intravitreal Injectable Sales by Drug (2017-2028)
6.1.2 North America Intravitreal Injectable Revenue by Drug (2017-2028)
6.2 North America Intravitreal Injectable Market Size by Disease
6.2.1 North America Intravitreal Injectable Sales by Disease (2017-2028)
6.2.2 North America Intravitreal Injectable Revenue by Disease (2017-2028)
6.3 North America Intravitreal Injectable Market Size by Country
6.3.1 North America Intravitreal Injectable Sales by Country (2017-2028)
6.3.2 North America Intravitreal Injectable Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intravitreal Injectable Market Size by Drug
7.1.1 Europe Intravitreal Injectable Sales by Drug (2017-2028)
7.1.2 Europe Intravitreal Injectable Revenue by Drug (2017-2028)
7.2 Europe Intravitreal Injectable Market Size by Disease
7.2.1 Europe Intravitreal Injectable Sales by Disease (2017-2028)
7.2.2 Europe Intravitreal Injectable Revenue by Disease (2017-2028)
7.3 Europe Intravitreal Injectable Market Size by Country
7.3.1 Europe Intravitreal Injectable Sales by Country (2017-2028)
7.3.2 Europe Intravitreal Injectable Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravitreal Injectable Market Size by Drug
8.1.1 Asia Pacific Intravitreal Injectable Sales by Drug (2017-2028)
8.1.2 Asia Pacific Intravitreal Injectable Revenue by Drug (2017-2028)
8.2 Asia Pacific Intravitreal Injectable Market Size by Disease
8.2.1 Asia Pacific Intravitreal Injectable Sales by Disease (2017-2028)
8.2.2 Asia Pacific Intravitreal Injectable Revenue by Disease (2017-2028)
8.3 Asia Pacific Intravitreal Injectable Market Size by Region
8.3.1 Asia Pacific Intravitreal Injectable Sales by Region (2017-2028)
8.3.2 Asia Pacific Intravitreal Injectable Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intravitreal Injectable Market Size by Drug
9.1.1 Latin America Intravitreal Injectable Sales by Drug (2017-2028)
9.1.2 Latin America Intravitreal Injectable Revenue by Drug (2017-2028)
9.2 Latin America Intravitreal Injectable Market Size by Disease
9.2.1 Latin America Intravitreal Injectable Sales by Disease (2017-2028)
9.2.2 Latin America Intravitreal Injectable Revenue by Disease (2017-2028)
9.3 Latin America Intravitreal Injectable Market Size by Country
9.3.1 Latin America Intravitreal Injectable Sales by Country (2017-2028)
9.3.2 Latin America Intravitreal Injectable Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravitreal Injectable Market Size by Drug
10.1.1 Middle East and Africa Intravitreal Injectable Sales by Drug (2017-2028)
10.1.2 Middle East and Africa Intravitreal Injectable Revenue by Drug (2017-2028)
10.2 Middle East and Africa Intravitreal Injectable Market Size by Disease
10.2.1 Middle East and Africa Intravitreal Injectable Sales by Disease (2017-2028)
10.2.2 Middle East and Africa Intravitreal Injectable Revenue by Disease (2017-2028)
10.3 Middle East and Africa Intravitreal Injectable Market Size by Country
10.3.1 Middle East and Africa Intravitreal Injectable Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intravitreal Injectable Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
11.1.2 Regeneron Pharmaceuticals (Eylea) Overview
11.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 EyePoint Pharmaceuticals
11.3.1 EyePoint Pharmaceuticals Corporation Information
11.3.2 EyePoint Pharmaceuticals Overview
11.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EyePoint Pharmaceuticals Recent Developments
11.4 Genentech
11.4.1 Genentech Corporation Information
11.4.2 Genentech Overview
11.4.3 Genentech Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genentech Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genentech Recent Developments
11.5 Kanghong Pharmaceutical
11.5.1 Kanghong Pharmaceutical Corporation Information
11.5.2 Kanghong Pharmaceutical Overview
11.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kanghong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravitreal Injectable Industry Chain Analysis
12.2 Intravitreal Injectable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravitreal Injectable Production Mode & Process
12.4 Intravitreal Injectable Sales and Marketing
12.4.1 Intravitreal Injectable Sales Channels
12.4.2 Intravitreal Injectable Distributors
12.5 Intravitreal Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intravitreal Injectable Industry Trends
13.2 Intravitreal Injectable Market Drivers
13.3 Intravitreal Injectable Market Challenges
13.4 Intravitreal Injectable Market Restraints
14 Key Findings in The Global Intravitreal Injectable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravitreal Injectable Market Size Growth Rate by Drug, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Anti-VEGF
Table 3. Major Manufacturers of Steroids
Table 4. Major Manufacturers of Others
Table 5. Global Intravitreal Injectable Market Size Growth Rate by Disease, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Intravitreal Injectable Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 8. Global Intravitreal Injectable Sales Market Share by Region (2017-2022)
Table 9. Global Intravitreal Injectable Sales by Region (2023-2028) & (K Units)
Table 10. Global Intravitreal Injectable Sales Market Share by Region (2023-2028)
Table 11. Global Intravitreal Injectable Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Intravitreal Injectable Revenue Market Share by Region (2017-2022)
Table 13. Global Intravitreal Injectable Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Intravitreal Injectable Revenue Market Share by Region (2023-2028)
Table 15. Global Intravitreal Injectable Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Intravitreal Injectable Sales Share by Manufacturers (2017-2022)
Table 17. Global Intravitreal Injectable Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Intravitreal Injectable Revenue Share by Manufacturers (2017-2022)
Table 19. Intravitreal Injectable Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Intravitreal Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Intravitreal Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2021)
Table 22. Intravitreal Injectable Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Intravitreal Injectable Product Offered
Table 24. Date of Manufacturers Enter into Intravitreal Injectable Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 27. Global Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 28. Global Intravitreal Injectable Sales Share by Drug (2017-2022)
Table 29. Global Intravitreal Injectable Sales Share by Drug (2023-2028)
Table 30. Global Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 31. Global Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 32. Global Intravitreal Injectable Revenue Share by Drug (2017-2022)
Table 33. Global Intravitreal Injectable Revenue Share by Drug (2023-2028)
Table 34. Intravitreal Injectable Price by Drug (2017-2022) & (US$/Unit)
Table 35. Global Intravitreal Injectable Price Forecast by Drug (2023-2028) & (US$/Unit)
Table 36. Global Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 37. Global Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 38. Global Intravitreal Injectable Sales Share by Disease (2017-2022)
Table 39. Global Intravitreal Injectable Sales Share by Disease (2023-2028)
Table 40. Global Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 41. Global Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 42. Global Intravitreal Injectable Revenue Share by Disease (2017-2022)
Table 43. Global Intravitreal Injectable Revenue Share by Disease (2023-2028)
Table 44. Intravitreal Injectable Price by Disease (2017-2022) & (US$/Unit)
Table 45. Global Intravitreal Injectable Price Forecast by Disease (2023-2028) & (US$/Unit)
Table 46. North America Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 47. North America Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 48. North America Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 49. North America Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 50. North America Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 51. North America Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 52. North America Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 53. North America Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 54. North America Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 55. North America Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 56. North America Intravitreal Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Intravitreal Injectable Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 59. Europe Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 60. Europe Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 61. Europe Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 62. Europe Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 63. Europe Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 64. Europe Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 65. Europe Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 66. Europe Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 67. Europe Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 68. Europe Intravitreal Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Intravitreal Injectable Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 71. Asia Pacific Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 72. Asia Pacific Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 73. Asia Pacific Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 74. Asia Pacific Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 75. Asia Pacific Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 76. Asia Pacific Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 77. Asia Pacific Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 78. Asia Pacific Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Intravitreal Injectable Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Intravitreal Injectable Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Intravitreal Injectable Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 83. Latin America Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 84. Latin America Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 85. Latin America Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 86. Latin America Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 87. Latin America Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 88. Latin America Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 89. Latin America Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 90. Latin America Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Intravitreal Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Intravitreal Injectable Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 95. Middle East and Africa Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 96. Middle East and Africa Intravitreal Injectable Revenue by Drug (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Intravitreal Injectable Revenue by Drug (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 99. Middle East and Africa Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 100. Middle East and Africa Intravitreal Injectable Revenue by Disease (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Intravitreal Injectable Revenue by Disease (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Intravitreal Injectable Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Intravitreal Injectable Revenue by Country (2023-2028) & (US$ Million)
Table 106. Regeneron Pharmaceuticals (Eylea) Corporation Information
Table 107. Regeneron Pharmaceuticals (Eylea) Description and Major Businesses
Table 108. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Regeneron Pharmaceuticals (Eylea) Recent Developments
Table 111. Allergan Corporation Information
Table 112. Allergan Description and Major Businesses
Table 113. Allergan Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Allergan Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Allergan Recent Developments
Table 116. EyePoint Pharmaceuticals Corporation Information
Table 117. EyePoint Pharmaceuticals Description and Major Businesses
Table 118. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. EyePoint Pharmaceuticals Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. EyePoint Pharmaceuticals Recent Developments
Table 121. Genentech Corporation Information
Table 122. Genentech Description and Major Businesses
Table 123. Genentech Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Genentech Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Genentech Recent Developments
Table 126. Kanghong Pharmaceutical Corporation Information
Table 127. Kanghong Pharmaceutical Description and Major Businesses
Table 128. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Kanghong Pharmaceutical Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Kanghong Pharmaceutical Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Intravitreal Injectable Distributors List
Table 134. Intravitreal Injectable Customers List
Table 135. Intravitreal Injectable Market Trends
Table 136. Intravitreal Injectable Market Drivers
Table 137. Intravitreal Injectable Market Challenges
Table 138. Intravitreal Injectable Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravitreal Injectable Product Picture
Figure 3. Global Intravitreal Injectable Market Share by Drug in 2021 & 2028
Figure 3. Anti-VEGF Product Picture
Figure 4. Steroids Product Picture
Figure 5. Others Product Picture
Figure 6. Global Intravitreal Injectable Market Share by Disease in 2021 & 2028
Figure 7. Macular Degeneration
Figure 8. Macular Edema
Figure 9. Uveitis
Figure 10. Retinal Vein Occlusion
Figure 11. Others
Figure 12. Intravitreal Injectable Report Years Considered
Figure 13. Global Intravitreal Injectable Sales 2017-2028 (K Units)
Figure 14. Global Intravitreal Injectable Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Intravitreal Injectable Revenue 2017-2028 (US$ Million)
Figure 16. Global Intravitreal Injectable Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Intravitreal Injectable Sales Market Share by Region (2017-2022)
Figure 18. Global Intravitreal Injectable Sales Market Share by Region (2023-2028)
Figure 19. North America Intravitreal Injectable Sales YoY (2017-2028) & (K Units)
Figure 20. North America Intravitreal Injectable Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Intravitreal Injectable Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Intravitreal Injectable Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Intravitreal Injectable Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Intravitreal Injectable Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Intravitreal Injectable Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Intravitreal Injectable Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Intravitreal Injectable Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Intravitreal Injectable Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Intravitreal Injectable Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Intravitreal Injectable in the World: Market Share by Intravitreal Injectable Revenue in 2021
Figure 31. Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 33. Global Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 34. Global Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 35. Global Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 36. North America Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 37. North America Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 38. North America Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 39. North America Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 40. North America Intravitreal Injectable Sales Share by Country (2017-2028)
Figure 41. North America Intravitreal Injectable Revenue Share by Country (2017-2028)
Figure 42. United States Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 45. Europe Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 46. Europe Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 47. Europe Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 48. Europe Intravitreal Injectable Sales Share by Country (2017-2028)
Figure 49. Europe Intravitreal Injectable Revenue Share by Country (2017-2028)
Figure 50. Germany Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 51. France Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 56. Asia Pacific Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 57. Asia Pacific Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 58. Asia Pacific Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 59. Asia Pacific Intravitreal Injectable Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Intravitreal Injectable Revenue Share by Region (2017-2028)
Figure 61. China Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 64. India Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 71. Latin America Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 72. Latin America Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 73. Latin America Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 74. Latin America Intravitreal Injectable Sales Share by Country (2017-2028)
Figure 75. Latin America Intravitreal Injectable Revenue Share by Country (2017-2028)
Figure 76. Mexico Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 80. Middle East and Africa Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 81. Middle East and Africa Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 82. Middle East and Africa Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 83. Middle East and Africa Intravitreal Injectable Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Intravitreal Injectable Revenue Share by Country (2017-2028)
Figure 85. Turkey Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Intravitreal Injectable Revenue (2017-2028) & (US$ Million)
Figure 88. Intravitreal Injectable Value Chain
Figure 89. Intravitreal Injectable Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
